1月21日,百利天恒股价报收193.71元/股,较24.7元/股的发行价上涨684.25%,成为生物医药板块近年来为数不多股价大幅上涨的药企。连亏三年后,百利天恒(688506.SH)实现扭亏为盈。1月20日晚,百利天恒发布业绩预告,经公司财务部门初步测算,预计2024年度实现营业收入为58亿元左右,与上年同期相比将增加52.38亿元左右,同比增加约932.27%;预计实现归母净利润36亿元左右,...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.